Orsiro Mission
Payments companies reported to CMS as associated with Orsiro Mission. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Orsiro Mission, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Orsiro Mission
These are the largest totals companies reported as associated with Orsiro Mission. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Ron Waksman | Washington, DC | Interventional Cardiology | $146,352.73 |
| Robert Stoler | Dallas, TX | Interventional Cardiology | $10,026.37 |
| Sasrutha Wickramasinghe | Houston, TX | Cardiovascular Disease | $9,737.10 |
| Rajiv Jauhar | New Hyde Park, NY | Cardiovascular Disease | $6,411.38 |
| Aditya Sharma | Carlisle, PA | Interventional Cardiology | $5,968.93 |
| Ajay Kirtane | New York, NY | Interventional Cardiology | $5,541.82 |
| Vamsi Krishna | Kyle, TX | Interventional Cardiology | $2,402.00 |
| Garrett Wong | Sacramento, CA | Cardiovascular Disease | $1,792.64 |
| Reza Nazari | Turlock, CA | Cardiovascular Disease | $1,701.73 |
| Nathan Kander | Columbus, OH | Interventional Cardiology | $1,232.08 |
Prescribed Orsiro Mission?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.